In this divagation on whether or not 5-HT2A is an important molecular target in the treatment of depression, one should remember that the several decades-long research on pathomechanism and pharmacotherapy of this condition revealed that some receptor subtypes should be blocked (e.g., 5-HT2A, 5-HT2C). The gene discussed is HTR2A; the disease is depressive symptom measurement.